Kamilia Motawea Mohammed Hassballah
Demonstrator
Prevalence of Thyroid Disorders among Pregnant Women in Banha City, Egypt a Hospital Based Cross Section Study
• 2024
Publication Information
Authors
Prof. Dr Mohamed Shawky El-sayed,
Prof. Dr Ayman Mohamed Al badawy,
Assis. Prof. Dr Rasha Omar Abd Elmoniem,
Dr Walaa Mohamed lbrahem,
Kamilia Motawea Mohammed
Keywords
Not Available
Journal
Not Available
Publisher
Not Available
Volume
Not Available
Issue
Not Available
Pages
Not Available
publication.type
Local
Paper Link
Not Available
Supplementary Materials
Not Available
Abstract
Background: Thyroid disorders rank as one of the prevailing endocrine disorders frequently observed during the course of pregnancy. This study assessed the thyroid disorders frequency among pregnant women residing in Banha City, Egypt, elucidating the types of disorders, their distribution across trimesters, and potential correlations with demographic factors, obstetric history, and thyroid function test results. Methods: This Cross Section Study included 173 pregnant females with abnormal thyroid function. In each case, a comprehensive history was obtained, and a thorough clinical examination was conducted [demographic data, drugs, obstetric history, previous pregnancy outcome and complication, manifestation on thyroid dysfunction and family history of thyroid diseases], lab investigation [ serum TSH serum freeT3 & serum freeT4, TSH value of American Thyroid Association (ATA) 2011]. Results: According to abortion history, overt hyperthyroidism is more likely to have a higher number of abortions compared to those with gestational or subclinical hyperthyroidism (p=0.007). There was significant higher median number of abortions in overt hyperthyroidism group compared with gestational hyperthyroidism group (p=0.033), although a significant higher median number of abortions in overt hyperthyroidism group compared with subclinical hyperthyroidism group (p=0.002). overt hypothyroidism was more likely to have a higher number of abortions compared to those with isolated maternal hypothyroxinemia or subclinical hypothyroidism (p
